ISIN | CH0578494434 |
---|---|
Valor Number | 57849443 |
Bloomberg Global ID | |
Fund Name | Swiss Life Funds (CH) Equity Switzerland Protect Enhanced I-A1 |
Fund Provider |
Swiss Life Asset Management AG
Zürich, Switzerland Phone: +41 44 284 77 09 E-Mail: info@swisslife-am.com Web: www.swisslife-am.com |
Fund Provider | Swiss Life Asset Management AG |
Representative in Switzerland | |
Distributor(s) |
Swiss Life AG Zürich Phone: +41 43 284 33 11 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | Das Anlageziel des „Swiss Life Funds (CH) Equity Switzerland Protect Enhanced“ besteht hauptsächlich darin, in Schweizer Franken einen langfristigen Kapitalzuwachs verbunden mit angemessenem Ertrag bei weitgehender Reduktion des Verlustrisikos zu erzielen.Dieser Anlagefonds investiert in erster Linie direkt oder indirekt in Beteiligungswertpapiere und -rechte (Aktien, Genussscheine, Genossenschaftsanteile, Partizipationsscheine und Ähnliches) von Gesellschaften, die im Swiss Market Index (SMI®) enthalten sind. |
Peculiarities |
Current Price * | 104.23 CHF | 10.04.2025 |
---|---|---|
Previous Price * | 102.52 CHF | 09.04.2025 |
52 Week High * | 117.70 CHF | 03.03.2025 |
52 Week Low * | 102.52 CHF | 09.04.2025 |
NAV * | 104.23 CHF | 10.04.2025 |
Issue Price * | 104.23 CHF | 10.04.2025 |
Redemption Price * | 104.23 CHF | 10.04.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 105,899,997 | |
Unit/Share Assets *** | 105,899,997 | |
Trading Information SIX |
YTD Performance | -3.72% |
31.12.2024 - 09.04.2025
31.12.2024 09.04.2025 |
---|---|---|
1 month | -12.04% |
10.03.2025 - 09.04.2025
10.03.2025 09.04.2025 |
3 months | -5.88% |
09.01.2025 - 09.04.2025
09.01.2025 09.04.2025 |
6 months | -7.41% |
09.10.2024 - 09.04.2025
09.10.2024 09.04.2025 |
1 year | -2.45% |
09.04.2024 - 09.04.2025
09.04.2024 09.04.2025 |
2 years | +0.48% |
11.04.2023 - 09.04.2025
11.04.2023 09.04.2025 |
3 years | -5.24% |
12.04.2022 - 09.04.2025
12.04.2022 09.04.2025 |
5 years | +9.96% |
07.12.2020 - 09.04.2025
07.12.2020 09.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 10.71% | |
---|---|---|
Roche Holding AG | 10.06% | |
Nestle SA | 9.89% | |
UBS Group AG | 5.16% | |
Zurich Insurance Group AG | 4.58% | |
ABB Ltd | 4.55% | |
Compagnie Financiere Richemont SA Class A | 3.69% | |
Holcim Ltd | 2.73% | |
Lonza Group Ltd | 2.20% | |
Alcon Inc | 2.20% | |
Last data update | 30.11.2024 |
TER *** | 0.15% |
---|---|
TER date *** | 31.12.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.15% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |